Welcome to the Oncology Brothers podcast! In this episode, Drs. Rohit and Rahul Gosain are joined by Dr. Ghassan Abou-Alfa, a medical oncologist specializing in the hepatobiliary space at Memorial Sloan Kettering. Together, they explored the current treatment landscape of biliary tract cancer, focusing on the advancements in HER2-driven therapies.

Key topics discussed included:

• The evolution of treatment options for biliary tract cancer, including chemotherapy and immunotherapy.

• The significance of genetic testing, including IDH1 mutations, FGFR alterations, and HER2 status.

• The role of multidisciplinary collaboration in managing hepatobiliary cancers.

• Insights into the latest clinical trials and emerging therapies for HER2-positive biliary tract cancer.

Join us as we delve into the complexities of biliary tract cancer and the promising developments in HER2-targeted treatments. Don't forget to check out our next episode, where we will take a deeper dive into the data surrounding HER2 therapies and discuss management strategies for common side effects.

YouTube: https://youtu.be/pGiU7JJGNOc

Follow us on social media:

•⁠  ⁠X/Twitter: https://twitter.com/oncbrothers

•⁠  ⁠Instagram: https://www.instagram.com/oncbrothers

•⁠  Website: https://oncbrothers.com/

Subscribe to stay updated on the latest in oncology!

#OncologyBrothers #BiliaryTractCancer #HER2 #CancerTreatment #MedicalOncology #CME #Podcast